Corporate Banner
Satellite Banner
Technology Networks Header
Wednesday, September 03, 2014
Technology Networks
Register | Sign in
Home Page>News

  News Archive

ELC Group Appoints Head of Regulatory Affairs for Russia and CIS
Tuesday, July 29, 2014
Inna Demidova to head new Moscow office for fast-growing global regulatory affairs specialist.

MorphoSys Provides Update on the Company's Proprietary Drug Portfolio
Tuesday, July 29, 2014
Early-stage portfolio now fully Ylanthia-based, includes programs with Merck Serono as well as first anti-GPCR programs.

Cypher Genomics, Illumina Enter Biomarker Agreement
Saturday, July 26, 2014
Co-promotion agreement to facilitate genomic biomarker discovery.

Atox Bio Closes $23 Million Investment
Friday, July 25, 2014
Funds will be used to advance development of AB103, a novel therapy for the treatment of necrotizing soft tissue infections.

Shire Enters Strategic Licensing and Collaboration Agreement with ArmaGen
Thursday, July 24, 2014
Strengthens leadership position in treatments for Hunter syndrome and commitment to MPS II patient community.

Camargo Strengthens Research Team and Therapeutic Expertise
Thursday, July 24, 2014
Company announces addition of Dr. Wen-Yee Choi, Dr. Jillian Orans, Dr. Vien Lai and Kathryn Kemme.

Ultragenyx Appoints Sunil Agarwal as Chief Medical Officer and Senior Vice President
Thursday, July 24, 2014
Dr. Agarwal joins experienced senior medical team at Ultragenyx.

Novasep Passes FDA Inspections on Two Sites
Thursday, July 24, 2014
Novasep wins approval to produce new molecular entity for US market.

RVX-208 Reduces MACE Significantly in Patients with Diabetes Mellitus
Thursday, July 24, 2014
In addition, preliminary results from an Australian sponsored trial have yet to verify whether the mechanism of RVX-208 action may affect glucose metabolism.

<< 2 3 4 5 6 7 8 >>
Showing Results 41 - 50 of 3115
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to